Table 2.
Enzyme 1 | Substrate 2 | Relative Activity (%) | Vmax [U/mg] | KM [mM] | Vmax/KM [U/mg/mM] |
---|---|---|---|---|---|
OxdB [14] |
IAOx | 18 | 5.42 | 2.40 | 2.26 |
iVaOx | 20 | 7.72 | 3.58 | 2.16 | |
Z-PAOx | 100 | 19.5 | 0.872 | 22.4 | |
Z-PPOx | 63 | 14.3 | 1.36 | 10.5 | |
OxdK [21] |
IAOx | 1 | n.d. | n.d. | n.d. |
iBuOx | 14 | 5.87 | 0.538 | 10.9 | |
iVaOx | 100 | 35.1 | 1.33 | 26.4 | |
Z-PAOx | 7 | 2.61 | 0.991 | 2.63 | |
Z-PPOx | 31 | 12.1 | 0.975 | 12.4 | |
OxdRG [22] |
IAOx | 11 | 0.281 | 3.91 | 0.072 |
iBuOx | 39 | 0.041 | 5.54 | 0.007 | |
iVaOx | 87 | 0.239 | 3.97 | 0.060 | |
Z-PAOx | 40 | 0.140 | 1.40 | 0.100 | |
Z-PPOx | 100 | 0.392 | 2.31 | 0.170 |
1 See Table 1. 2 IAOx, indole-3-acetaldoxime; iBuOx, isobutyraldoxime; iVaOx, isovaleraldoxime (3-methylbutyraldoxime); PAOx, phenylacetaldoxime; PPOx, 3-phenylpropionaldoxime. The substrates are of E/Z-configuration unless noted otherwise. Substrates with the highest relative activity and Vmax/KM are in bold.